CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (USD $) In Thousands, unless otherwise specified	Total USD ($)	Compensation USD ($)	Services USD ($)	Lawsuits USD ($)	Debt USD ($)	Convertible Notes Payable USD ($)	Preferred Stock Par Value $0.001 USD ($)	Preferred Stock Par Value $0.001 Series E preferred stock and cumulative dividends USD ($)	Common Stock Par Value $0.001 USD ($)	Common Stock Par Value $0.001 Compensation	Common Stock Par Value $0.001 Services USD ($)	Common Stock Par Value $0.001 Lawsuits USD ($)	Common Stock Par Value $0.001 Debt	Common Stock Par Value $0.001 Series E preferred stock and cumulative dividends	Common Stock Par Value $0.001 Warrant	Common Stock Par Value $0.001 Convertible Notes Payable USD ($)	Treasury Stock USD ($)	Additional Paid-In Capital USD ($)	Additional Paid-In Capital Compensation USD ($)	Additional Paid-In Capital Services USD ($)	Additional Paid-In Capital Lawsuits USD ($)	Additional Paid-In Capital Debt USD ($)	Additional Paid-In Capital Series E preferred stock and cumulative dividends USD ($)	Additional Paid-In Capital Convertible Notes Payable USD ($)	Accumulated Deficit USD ($)	Accumulated Other Comprehensive Loss USD ($)
Beginning Balance at Dec. 31, 2009	$ (2,115)						$ 1,492		$ 42								$ (327)	$ 92,106							$ (95,351)	$ (77)
Beginning Balance (in shares) at Dec. 31, 2009							373,555		42,173,810								19,209
Comprehensive Loss:
Net loss	(2,097)																								(2,097)
Total net comprehensive loss	(2,097)
Exercise of warrants (in shares)									485,000
Exercise of warrants									1									(1)
Sales of common stock (in shares)									1,333,333
Sales of common stock	100								1									99
Conversion to common stock (in shares)									1,060,626
Conversion to common stock	20								1									19
Charge for derivative liability	(378)																	(378)
Common stock issued (in shares)										450,000	150,806	2,658,800	66,667
Common stock issued		36	36	505	10							3							36	36	502	10
Interest imputed on related party advances	109																	109
Warrants issued		1		33															1		33
Ending Balance at Dec. 31, 2010	(3,740)						1,492		48								(327)	92,572							(97,448)	(77)
Ending Balance (in shares) at Dec. 31, 2010							373,555		48,379,042								19,209
Comprehensive Loss:
Net loss	(2,876)																								(2,876)
Foreign currency translation	(1)																									(1)
Total net comprehensive loss	(2,877)
Conversion to common stock (in shares)								(200)						10,916		7,306,588
Conversion to common stock						58		(5)								7							5	51
Charge for derivative liability	69																	69
Common stock issued (in shares)											7,603,253				4,716
Common stock issued			101								8									93
Interest imputed on related party advances	173																	173
Common stock issued for compensation (in shares)									3,104,179
Common stock issued for compensation	44								3									41
Ending Balance at Dec. 31, 2011	$ (6,172)						$ 1,487		$ 66								$ (327)	$ 93,004							$ (100,324)	$ (78)
Ending Balance (in shares) at Dec. 31, 2011							373,355		66,408,694								19,209